IVRA FDA approval date

The FDA approved IVRA on 18 Aug 2023.

FDA approval date
18 Aug 2023

Drug identity has not yet been verified against registry records

Also recorded as MELPHALAN HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-08-18DayIVRAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217110", "applicant_as_listed_by_fda": "APOTEX", "brand_names": ["IVRA"], "active_ingredients": ["MELPHALAN HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230818", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026